vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Primerica, Inc. (PRI). Click either name above to swap in a different company.
Primerica, Inc. is the larger business by last-quarter revenue ($853.7M vs $829.0M, roughly 1.0× Acadia Healthcare Company, Inc.). Primerica, Inc. runs the higher net margin — 23.1% vs 0.5%, a 22.5% gap on every dollar of revenue. On growth, Primerica, Inc. posted the faster year-over-year revenue change (11.0% vs 7.5%). Over the past eight quarters, Primerica, Inc.'s revenue compounded faster (7.2% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Primerica, Inc. is a multi-level marketing company that provides insurance, investment and financial services to middle-income families in the United States and Canada.
ACHC vs PRI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $853.7M |
| Net Profit | $4.5M | $197.0M |
| Gross Margin | — | — |
| Operating Margin | — | 28.9% |
| Net Margin | 0.5% | 23.1% |
| Revenue YoY | 7.5% | 11.0% |
| Net Profit YoY | -50.8% | 17.9% |
| EPS (diluted) | $0.05 | $6.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $853.7M | ||
| Q3 25 | $851.6M | $839.9M | ||
| Q2 25 | $869.2M | $793.3M | ||
| Q1 25 | $770.5M | $804.8M | ||
| Q4 24 | $774.2M | $768.8M | ||
| Q3 24 | $815.6M | $774.1M | ||
| Q2 24 | $796.0M | $803.4M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $197.0M | ||
| Q3 25 | $36.2M | $206.8M | ||
| Q2 25 | $30.1M | $178.3M | ||
| Q1 25 | $8.4M | $169.1M | ||
| Q4 24 | $32.6M | $167.1M | ||
| Q3 24 | $68.1M | $164.4M | ||
| Q2 24 | $78.5M | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 98.0% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 28.9% | ||
| Q3 25 | 4.7% | 32.3% | ||
| Q2 25 | 5.8% | 29.6% | ||
| Q1 25 | 1.7% | 27.5% | ||
| Q4 24 | 4.9% | 64.7% | ||
| Q3 24 | 12.1% | 32.9% | ||
| Q2 24 | 13.4% | 1.0% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 23.1% | ||
| Q3 25 | 4.3% | 24.6% | ||
| Q2 25 | 3.5% | 22.5% | ||
| Q1 25 | 1.1% | 21.0% | ||
| Q4 24 | 4.2% | 21.7% | ||
| Q3 24 | 8.4% | 21.2% | ||
| Q2 24 | 9.9% | 0.1% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $6.11 | ||
| Q3 25 | $0.40 | $6.35 | ||
| Q2 25 | $0.33 | $5.40 | ||
| Q1 25 | $0.09 | $5.05 | ||
| Q4 24 | $0.36 | $4.92 | ||
| Q3 24 | $0.74 | $4.83 | ||
| Q2 24 | $0.85 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $756.2M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $2.4B |
| Total Assets | $5.5B | $15.0B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $756.2M | ||
| Q3 25 | $118.7M | $644.9M | ||
| Q2 25 | $131.4M | $621.2M | ||
| Q1 25 | $91.2M | $625.1M | ||
| Q4 24 | $76.3M | $687.8M | ||
| Q3 24 | $82.1M | $550.1M | ||
| Q2 24 | $77.2M | $627.3M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.4B | ||
| Q3 25 | $3.1B | $2.3B | ||
| Q2 25 | $3.1B | $2.3B | ||
| Q1 25 | $3.0B | $2.3B | ||
| Q4 24 | $3.1B | $2.3B | ||
| Q3 24 | $3.0B | $1.9B | ||
| Q2 24 | $3.0B | $2.1B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $15.0B | ||
| Q3 25 | $6.4B | $14.8B | ||
| Q2 25 | $6.3B | $14.8B | ||
| Q1 25 | $6.1B | $14.6B | ||
| Q4 24 | $6.0B | $14.6B | ||
| Q3 24 | $5.9B | $14.8B | ||
| Q2 24 | $5.7B | $14.6B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $338.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.78× | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $338.2M | ||
| Q3 25 | $73.2M | $202.9M | ||
| Q2 25 | $133.5M | $162.6M | ||
| Q1 25 | $11.5M | $197.5M | ||
| Q4 24 | $116.7M | $270.6M | ||
| Q3 24 | $163.1M | $207.3M | ||
| Q2 24 | $171.1M | $173.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | — |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 1.72× | ||
| Q3 25 | 2.02× | 0.98× | ||
| Q2 25 | 4.43× | 0.91× | ||
| Q1 25 | 1.37× | 1.17× | ||
| Q4 24 | 3.58× | 1.62× | ||
| Q3 24 | 2.39× | 1.26× | ||
| Q2 24 | 2.18× | 147.98× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
PRI
| Revenues From Sources Other Than Contracts With Customers | $445.9M | 52% |
| Investment And Savings Products Segment Revenues | $340.3M | 40% |
| Other | $56.5M | 7% |
| Segment Revenues From Contracts With Customers | $11.0M | 1% |
